[Mortality and associated prognostic factors in elderly and very elderly hospitalized patients with respiratory disease COVID-19]Observational Study Published on 2021-09-012022-10-05 Journal: Revista española de geriatría y gerontología [Category] SARS, 임상, [키워드] age Aged Anciano anticoagulant therapy anticoagulation therapy calcium antagonist Chronic kidney disease Clinical characteristics clinical evolution Clinical outcome collected COVID-19 Cox regression model develop discharge elderly Elderly patient English Follow-up Hospitalization hospitalized patient hypertensive information laboratory data Manifestations media Mortality mortality rate Muy anciano Oldest old. Patient patients patients hospitalized patients with COVID-19 Prognostic factor Prognostic factors renal Respiratory disease respiratory infection SARS-CoV-2 SARS-COV-2 infection Spanish survival susceptible therapeutic intervention Treatment variable with COVID-19 [DOI] 10.1016/j.regg.2020.09.006 PMC 바로가기 [Article Type] Observational Study
Aortic arch thrombosis complicated by an embolic stroke in a patient with COVID-19: A case reportCase Report Published on 2021-08-232022-10-28 Journal: Annals of Medicine and Surgery [Category] COVID-19, [키워드] absence anticoagulant therapy aortic arch Aortic thrombosis Case report clinical clinical suspicion clinician Coagulopathy complications cough COVID-19 COVID-19 case COVID-19 cases COVID-19 patient embolic Endothelium events explain Fever Floating hospital hyperinflammatory state infect Ischemia limb management guideline nasopharyngeal Occurrence pandemic pathophysiology Patient PCR Pneumonia polymerase chain presenting repeated reported required SARS-CoV-2 severe cases stroke the patient Thromboembolic events thrombosis Thrombus tomography venous vessels [DOI] 10.1016/j.amsu.2021.102760 PMC 바로가기 [Article Type] Case Report
Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case reportCase Report Published on 2021-08-232022-10-28 Journal: Open Life Sciences [Category] COVID-19, [키워드] accompanied administration anticoagulant therapy assist association body temperature C reactive protein Case report clinical manifestation Clinical treatment Coagulation Coronavirus disease 2019 COVID-19 Cytokine storm D-dimer decrease disease dropped Hypoxemia IL-6 Inflammation interleukin-6 mechanism microthrombus oxygenation index Patient Research SARS-CoV-2 Severe case severe COVID-19 severe patients Tocilizumab treatment strategy [DOI] 10.1515/biol-2021-0088 PMC 바로가기 [Article Type] Case Report
Effect of Anticoagulant Administration on the Mortality of Hospitalized Patients With COVID-19: An Updated Systematic Review and Meta-AnalysisMedicine Published on 2021-08-042022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] 95% CI 95% confidence interval administration Anticoagulant anticoagulant therapy anticoagulation assessment benefit bleeding bleeding event bleeding events coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient Critically ill decreased mortality development Effect Evidence heparin hospital hospitalized COVID-19 patient hospitalized patient incidence Inconclusive intensive care unit lower mortality risk Meta-analysis Mortality observational study patients with COVID-19 random-effects model review risk systematic review therapy Thromboprophylaxis Trial variable was used with COVID-19 [DOI] 10.3389/fmed.2021.698935 PMC 바로가기 [Article Type] Medicine
Serum Metabolic Profile in Patients With Long-C ovid (PASC) Syndrome: Clinical ImplicationsMedicine Published on 2021-07-222022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] albumin alteration Anti-inflammatory anticoagulant therapy Blood clinical clinical conditions clinically Coagulation Concentration concomitant disease COVID-19 CRP D-dimer Dyspnea Elevation erythrocyte sedimentation rate evaluated fatigue ferritin hemoglobin hospital discharge implicated indicated Inflammation knowledge LDH Long-COVID-syndrome Long-term follow-up maintain marker metabolic metabolism molecular muscular PASC pathophysiology Patient patient symptom patients persistence profile Prophylactic Protein raise rehabilitation reported risk SARS-COV-2 infection SARS-CoV2 selected serum Seven Symptom syndrome thromboembolic disease virus infection weakness [DOI] 10.3389/fmed.2021.714426 PMC 바로가기 [Article Type] Medicine
Ruling out Pulmonary Embolism in Patients with (Suspected) COVID-19—A Prospective Cohort StudyOriginal Article Published on 2021-07-152022-10-29 Journal: TH Open: Companion Journal to Thrombosis and Haemostasis [Category] COVID-19, [키워드] 95% CI anticoagulant therapy applicability applied approach Computed tomography COVID-19 COVID-19 patient COVID-19 patients CTPA diagnosed Diagnosis diagnostic Diagnostic strategy Efficiency eight Embolism evaluated excluded Follow-up hemodynamic hospitals Informed consent initial multicenter outcome Patient patients Prevalence Prospective pulmonary pulmonary angiography Pulmonary embolism reflect Result Suspected tested thrombotic risk Venous Thromboembolism VTE was obtained well were excluded [DOI] 10.1055/s-0041-1735155 PMC 바로가기 [Article Type] Original Article
Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patientsResearch Published on 2021-06-162022-10-28 Journal: BMC Nephrology [Category] COVID-19, MERS, SARS, [키워드] Acute kidney injury acute renal failure Admission AKI Anticoagulant anticoagulant therapy anticoagulation chronic COVID-19 criteria determine diagnosis of COVID-19 disease Factor foundation global pandemic group hospitalised hypercoagulable hypertension incidence intensive care unit KDIGO Kidney disease less Male sex mechanical ventilation Mortality no difference occur outcome Patient patients with COVID-19 randomised controlled study receive reduced reduced risk renal renal replacement therapy Respiratory failure Result SARS-CoV2 severity supplementary material therapy thrombosis thrombotic Treatment Trust university unlikely were excluded World Health Organisation [DOI] 10.1186/s12882-021-02436-5 PMC 바로가기 [Article Type] Research
Efficacy of thromboelastography in the management of anticoagulation for veno-venous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient A case report코로나바이러스 질환 2019 환자에서 정맥-정맥 체외막 산소화를 위한 항응고제 관리에서 혈전탄성조영술의 효능 증례 보고Case Reports Published on 2021-06-112022-09-12 Journal: Medicine [Category] MERS, 진단, [키워드] activated Activated clotting time activated partial thromboplastin time acute respiratory distress acute respiratory distress syndrome addition adjusted angle Anticoagulant anticoagulant therapy anticoagulation approach aPTT Case report cause Clotting time Coagulopathy Complication coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID19 detect diagnoses dose doses ECMO elevated Evidence extracorporeal membrane oxygenation fibrinogen functional Hemorrhagic hemorrhaging heparin heparinase Hypercoagulation indicate indication infected with COVID-19 kaolin management marker multifactorial partial thromboplastin time Patient presenting reduce respiratory capacity respiratory distress syndrome the patient therapeutic therapy thromboelastography THROMBOPLASTIN thrombosis thrombotic Thrombotic complications V-V ECMO veno-venous extracorporeal membrane oxygenation Withdrawal worsening [DOI] 10.1097/MD.0000000000026313 PMC 바로가기 [Article Type] Case Reports
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 PneumoniaObservational Study Published on 2021-06-012022-10-05 Journal: Chest [Category] 임상, [키워드] 95% CI accounted Anticoagulant anticoagulant therapy anticoagulation bleeding clinical collected consecutive patient Controlled trial COVID-19 Critically ill patient defined dose eight favor French hazard ratio hemorrhage hemorrhagic events high risk High-dose ICU ICU admission Ill Impact incidence increased risk laboratory data Patient Probability Prophylactic Prophylaxis Pulmonary embolism recorded reduced risk reduction in risk SARS-COV-2 infection standardized protocol therapeutic thrombosis thrombotic thrombotic complication Treatment with COVID-19 [DOI] 10.1016/j.chest.2021.01.017 PMC 바로가기 [Article Type] Observational Study
Splenic infarction as a complication of covid-19 in a patient without respiratory symptoms: A case report and literature reviewCase Report Published on 2021-03-202022-10-30 Journal: IDCases [Category] COVID-19, [키워드] abdomen abdominal pain absence anticoagulant therapy anticoagulation bases benefit Case report Contact COVID-19 COVID-19 patient criteria D-dimer D-dimer levels discharged home Disseminated intravascular coagulation elevated ground-glass opacity imaging Infarction literature review moderate Multiple organ Patient positive pro-thrombotic recorded respiratory manifestation respiratory symptom respiratory symptoms rivaroxaban SARS-CoV-2 SARS-COV-2 infection Splenic Splenic infarction tested the disease thrombotic event treated Vascular visceral [DOI] 10.1016/j.idcr.2021.e01062 PMC 바로가기 [Article Type] Case Report